Brief: Senti Biosciences Q3 Net Income USD -18.126 Million
13/11/2025 21:30
Nov 13 (Reuters) - Senti Biosciences Q3 operating expenses USD 16.948 million. Q3 operating income USD -16.948 million Q3 EPS USD -0.69
Recent news on Senti Biosciences Holdings
See all newsSenti Biosciences Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:25 AM
Brief: Senti Biosciences Says Offering 15.97 Million Shares Of Common Stock For Resale By Selling Securityholder
Senti Biosciences Q1 net loss narrows on cost reduction